| Name | Relationship | Address | Signature | Signature date | CIK |
|---|---|---|---|---|---|
| Rondoni John | Officer | C/O INSPIRE MEDICAL SYSTEMS, INC., 5500 WAYZATA BLVD., SUITE 1600, GOLDEN VALLEY | /s/ Bryan Phillips, Attorney-in-Fact for John Rondoni | 12 Jan 2026 | 0001932219 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | INSP | Common Stock | Sale | $10,900 | -109 | -0.78% | $100.00 | 13,797 | 09 Jan 2026 | Direct | F1 |
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
| Id | Content |
|---|---|
| F1 | Includes 140 shares acquired under the Issuer's 2018 Employee Stock Purchase Plan since the Reporting Person's Form 4 dated May 21, 2025. |
Title: Chief Product and Innovation Officer. All sale transactions reported herein were made pursuant to a Rule 10b5-1 trading plan dated May 28, 2025.